Welcome, Guest. Please login or register.
April 01, 2020, 04:57:04 am

Login with username, password and session length

 

Members
Stats
  • Total Posts: 279
  • Total Topics: 141
  • Online Today: 13
  • Online Ever: 518
  • (January 21, 2020, 05:24:49 pm)
Users Online
Users: 0
Guests: 6
Total: 6

Welcome!

Welcome to the Cancer Health Forums, a round-the-clock discussion area for people who have any type of cancer, their friends and family and others with questions about living with cancer. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Cancer Health Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Cancer Immunotherapy Gets Assist From Micro-Scale Engineering  (Read 412 times)

Offline Cancer Health Editors

  • Jr. Member
  • **
  • Posts: 56
    • View Profile
Cancer Immunotherapy Gets Assist From Micro-Scale Engineering
« on: January 23, 2020, 11:04:58 am »
Today’s cancer treatments can sometimes feel like yesterday’s science fiction. In 2017, the Food and Drug Administration approved two therapies that manipulate immune cells’ DNA to give them the power to hunt down and kill certain blood cancers. Scientists are working to extend this treatment strategy to as many cancer types as possible, including solid tumors like breast and pancreatic cancers. But solid tumors pose new challenges even to empowered immune cells, such as the sheer number of cancer cells found in one solid-tumor mass.

Matthias Stephan, MD, PhD, at Fred Hutchinson Cancer Research Center developed a patented strategy to deliver active, genetically engineered anti-cancer immune cells to solid tumors, dramatically improving their efficacy in mouse models of cancer. Now, he’s combined this science-fiction cancer treatment with a science-fiction material to improve it even further.

In a study published Dec. 9 in the journal Nature Biomedical Engineering, Stephan showed that loading genetically engineered immune cells onto a metal micromesh-based tumor stent can keep tumors from growing into and blocking the stent in a preclinical model of pancreatic cancer. He and his team also demonstrated that the micromesh can also deliver curative, standardized doses of anti-cancer immune cells to mice with inoperable ovarian cancer.

Click here to read more...
https://www.cancerhealth.com/article/cancer-immunotherapy-gets-assist-microscale-engineering

 


© 2020 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.